Skip to main content

Neurocrine Biosciences Inc

NBIX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000914475

In the last 90 days, Neurocrine Biosciences Inc insiders filed 0 open-market purchases and 7 sales; 782 institutions reported holding it in 13F filings for Q2 2026, worth $17.0B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Neurocrine Biosciences Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
7 filings
6 insiders, $6.24M in total
Insiders trading
6
Net value
−$6.24M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Neurocrine Biosciences Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Neurocrine Biosciences Inc
NameTitleLast reported holdingLast filingFilings, past year
Onyia JudeChief Scientific Officer22,647Sep 15, 20269
Lippoldt DarinChief Legal Officer56,793Sep 15, 20267
Keswani Sanjay ChandruChief Medical Officer3,281Sep 15, 20263
Gorman Kevin CharlesDirector517,797Sep 15, 20265
Gano KyleChief Executive Officer154,728Sep 15, 20265
Delaet IngridChief Regulatory Officer18,289Sep 15, 20266
Cooke JulieChief Human Resources Officer24,025Sep 15, 20264
Boyer David W.Chief Corp. Affairs Officer8,722Sep 15, 20264
Benevich EricChief Commercial Officer67,297Sep 15, 20265
Abernethy MattChief Financial Officer42,808Sep 15, 20264
Sherwin Stephen ADirector14,860Sep 3, 20264
Norwalk Leslie VDirector2,430Jul 30, 20266
Morrow George JDirector10,386May 29, 20263
Lyons Gary ADirector122,141May 29, 20263
Pops Richard FDirector37,798May 29, 20263
Poon Christine ADirector4,753May 29, 20262
Rastetter William HDirector43,678May 29, 20263
Sharp ShaliniDirector4,088May 29, 20262
Mercier JohannaDirector6,853May 29, 20262
Roberts EiryChief Medical Officer35,640Feb 14, 20250
Lloyd-Smith MalcolmChief Integration Officer42,337Feb 8, 20230
Grigoriadis Dimitri E.Chief Research Officer82,273Feb 2, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 2, 2023 (view filing)Jan 312 daysLippoldt DarinChief Legal OfficerSSale−1.25K$109.97−$137.5K−4.0%30.4K after
Feb 2, 2023 (view filing)Jan 312 daysLloyd-Smith MalcolmChief Integration OfficerSSale−1.67K$110.02−$183.3K−5.5%28.6K after
Feb 2, 2023 (view filing)Jan 312 daysOnyia JudeChief Scientific OfficerSSale−126$108.48−$13.7K−4.8%2.48K after
Feb 2, 2023 (view filing)Jan 312 daysRoberts EiryChief Medical OfficerSSale−1.46K$109.99−$160.3K−5.3%26.2K after
Feb 8, 2023 (view filing)Feb 6-82 daysAbernethy MattChief Financial OfficerSSale−28.6K$102.61−$2.93M−53.1%25.2K after5 lots
Feb 8, 2023 (view filing)Feb 6-82 daysBenevich EricChief Commercial OfficerSSale−19.6K$102.70−$2.02M−36.4%34.4K after4 lots
Feb 8, 2023 (view filing)Feb 6-82 daysBoyer David W.Chief Corp. Affairs OfficerSSale−25.2K$102.49−$2.59M−84.1%4.75K after4 lots
Feb 8, 2023 (view filing)Feb 6-82 daysGano KyleChief Business Development OffSSale−17.0K$102.79−$1.75M−11.7%128.1K after4 lots
Feb 8, 2023 (view filing)Feb 6-82 daysGorman Kevin CharlesChief Executive OfficerSSale−29.0K$102.90−$2.99M−5.6%491.4K after4 lots
Feb 8, 2023 (view filing)Feb 6-82 daysLippoldt DarinChief Legal OfficerSSale−16.3K$102.71−$1.67M−26.6%45.0K after4 lots
Feb 8, 2023 (view filing)Feb 6-82 daysLloyd-Smith MalcolmChief Integration OfficerSSale−15.3K$102.64−$1.57M−26.6%42.3K after4 lots
Feb 8, 2023 (view filing)Feb 71 dayOnyia JudeChief Scientific OfficerSSale−4.51K$102.30−$461.2K−40.9%6.53K after
Feb 8, 2023 (view filing)Feb 6-82 daysRoberts EiryChief Medical OfficerSSale−16.5K$102.74−$1.70M−28.7%41.0K after4 lots
Feb 8, 2023 (view filing)Feb 6-82 daysCooke JulieChief Human Resources OfficerSSale−17.1K$102.77−$1.76M−38.4%27.4K after7 lots
Apr 21, 2023 (view filing)Apr 19-212 daysRastetter William HDirectorSSale−6.94K$105.03−$728.6K−15.0%39.5K after2 lots10b5-1
Apr 26, 2023 (view filing)Apr 242 daysRoberts EiryChief Medical OfficerSSale−14.4K$103.48−$1.49M−35.1%26.6K after10b5-1
Apr 27, 2023 (view filing)Apr 252 daysCooke JulieChief Human Resources OfficerSSale−100$103.82−$10.4K−0.4%27.6K after10b5-1
May 3, 2023 (view filing)May 12 daysCooke JulieChief Human Resources OfficerSSale−11.4K$103.89−$1.18M−41.3%16.2K after10b5-1
May 3, 2023 (view filing)May 12 daysRastetter William HDirectorSSale−4.30K$101.43−$436.1K−9.1%42.8K after10b5-1
Aug 23, 2023 (view filing)Aug 212 daysAbernethy MattChief Financial OfficerSSale−2.13K$107.39−$229.0K−7.3%27.1K after10b5-1
Aug 23, 2023 (view filing)Aug 212 daysBenevich EricChief Commercial OfficerSSale−1.60K$107.40−$171.8K−4.2%36.4K after10b5-1
Aug 23, 2023 (view filing)Aug 212 daysBoyer David W.Chief Corp. Affairs OfficerSSale−1.60K$107.41−$171.9K−20.5%6.19K after10b5-1
Aug 23, 2023 (view filing)Aug 212 daysCooke JulieChief Human Resources OfficerSSale−2.13K$107.41−$229.0K−10.5%18.1K after10b5-1
Aug 23, 2023 (view filing)Aug 212 daysDelaet IngridChief Regulatory OfficerSSale−1.40K$107.42−$150.8K−23.2%4.64K after10b5-1
Aug 23, 2023 (view filing)Aug 212 daysGano KyleChief Business Development OffSSale−2.13K$107.41−$229.0K−1.6%130.3K after10b5-1
Aug 23, 2023 (view filing)Aug 212 daysGorman Kevin CharlesChief Executive OfficerSSale−9.33K$107.40−$1.00M−1.8%499.8K after10b5-1
Aug 23, 2023 (view filing)Aug 212 daysLippoldt DarinChief Legal OfficerSSale−2.13K$107.39−$229.0K−4.3%47.0K after10b5-1
Aug 23, 2023 (view filing)Aug 212 daysOnyia JudeChief Scientific OfficerSSale−3.20K$107.37−$343.4K−24.9%9.64K after10b5-1
Aug 23, 2023 (view filing)Aug 212 daysRoberts EiryChief Medical OfficerSSale−3.20K$107.38−$343.4K−9.8%29.5K after10b5-1
Aug 30, 2023 (view filing)Aug 282 daysDelaet IngridChief Regulatory OfficerSSale−1.43K$107.52−$153.9K−19.4%5.93K after10b5-1
Sep 1, 2023 (view filing)Aug 302 daysBoyer David W.Chief Corp. Affairs OfficerSSale−2.73K$107.59−$294.1K−44.1%3.46K after2 lots10b5-1
Sep 6, 2023 (view filing)Sep 15 daysCooke JulieChief Human Resources OfficerSSale−824$110.93−$91.4K−4.6%17.3K after10b5-1
Sep 6, 2023 (view filing)Sep 15 daysLyons Gary ADirectorSSale−5.00K$110.06−$550.3K−2.4%203.7K after10b5-1
Sep 14, 2023 (view filing)Sep 122 daysLyons Gary ADirectorSSale−5.00K$115.02−$575.1K−2.4%203.7K after10b5-1
Oct 4, 2023 (view filing)Oct 22 daysBoyer David W.Chief Corp. Affairs OfficerSSale−1.44K$112.68−$161.9K−22.7%4.89K after10b5-1
Nov 29, 2023 (view filing)Nov 272 daysLippoldt DarinChief Legal OfficerSSale−10.9K$112.27−$1.23M−23.3%35.9K after10b5-1
Dec 1, 2023 (view filing)Nov 292 daysOnyia JudeChief Scientific OfficerSSale−2.33K$113.57−$264.7K−16.6%11.7K after10b5-1
Dec 5, 2023 (view filing)Dec 14 daysLyons Gary ADirectorSSale−5.00K$116.77−$583.9K−2.4%203.7K after10b5-1
Dec 8, 2023 (view filing)Dec 62 daysLippoldt DarinChief Legal OfficerSSale−20.8K$119.86−$2.50M−36.7%35.9K after10b5-1
Dec 8, 2023 (view filing)Dec 62 daysRoberts EiryChief Medical OfficerSSale−8.40K$120.03−$1.01M−22.1%29.5K after10b5-1
Dec 11, 2023 (view filing)Dec 7-84 daysRoberts EiryChief Medical OfficerSSale−77.7K$120.37−$9.35M−72.5%29.5K after6 lots10b5-1
Dec 14, 2023 (view filing)Dec 122 daysRoberts EiryChief Medical OfficerSSale−13.9K$120.30−$1.68M−32.1%29.5K after2 lots10b5-1
Dec 27, 2023 (view filing)Dec 225 daysCooke JulieChief Human Resources OfficerSSale−24.0K$128.66−$3.09M−58.2%17.3K after2 lots10b5-1
Dec 27, 2023 (view filing)Dec 225 daysLyons Gary ADirectorSSale−10.0K$130.04−$1.30M−4.9%193.7K after10b5-1
Dec 27, 2023 (view filing)Dec 225 daysRoberts EiryChief Medical OfficerSSale−10.0K$126.74−$1.27M−33.9%19.5K after10b5-1
Jan 4, 2024 (view filing)Jan 22 daysRastetter William HDirectorSSale−11.0K$131.47−$1.45M−17.6%51.7K after10b5-1
Jan 4, 2024 (view filing)Jan 22 daysGano KyleChief Business Development OffSSale−75.0K$131.47−$9.86M−36.5%130.3K after2 lots10b5-1
Jan 10, 2024 (view filing)Jan 8-92 daysGorman Kevin CharlesChief Executive OfficerSSale−167.9K$133.02−$22.3M−25.1%499.8K after2 lots10b5-1
Jan 24, 2024 (view filing)Jan 222 daysLippoldt DarinChief Legal OfficerSSale−10.0K$139.86−$1.40M−21.8%35.9K after10b5-1
Feb 2, 2024 (view filing)Jan 312 daysAbernethy MattChief Financial OfficerSSale−1.28K$140.72−$180.5K−4.3%28.3K after10b5-1